Teva Pharmaceutical Industries Limited
TEVA.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.04B
Close$
Share Statistics
| Market cap | $46.04 Billion |
|---|---|
| Enterprise Value | $59.26 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 9.10% |
|---|---|
| Return on Assets | 1.77% |
| Return on Invested Capital | 7.58% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.42 |
| Enterprise Value to EBIT | 32.29 |
| Enterprise Value to Net Income | 83 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 2.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 29, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$12.14 B
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$2.17
Average shareholder expectationRevenue Estimate
$12.99 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Teva- Pharmaceutical Industries Ltd.
33,346 employees
CEO: Kaare Schultz Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products througho...